CLICK4HP Archives

Health Promotion on the Internet

CLICK4HP@YORKU.CA

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"David Hock (US - NC)" <[log in to unmask]>
Reply To:
Health Promotion on the Internet <[log in to unmask]>
Date:
Thu, 7 May 2009 10:52:21 -0400
Content-Type:
text/plain
Parts/Attachments:
text/plain (23 lines)
Family Health International (FHI) is pleased to announce that a recent publication, Family Health Research: Microbicides for HIV Prevention<http://www.fhi.org/en/RH/Pubs/fhr/v2_2/index.htm>, is now available online. You will find it at:
http://www.fhi.org/en/RH/Pubs/fhr/v2_2/index.htm

Family Health Research is a newsletter designed to promote the use of evidence-based practices in reproductive health programs. Each issue examines a key topic in reproductive health care - offering the latest updates on innovative research and the programs that help to put that research into practice.

This issue of the newsletter describes efforts to develop a safe, effective, and acceptable vaginal microbicide to prevent HIV. Advocacy and support for microbicide research are strong, and an effective product - although likely years away - could help alleviate the HIV epidemic in sub-Saharan Africa and around the world.

FHI and its partners are working with women throughout the world to test a variety of candidate microbicides, including antiretroviral-based products such as tenofovir gel. They are also working with the broader microbicide community, which is preparing to introduce an effective product to the public if one becomes available.

Women have an especially high risk of HIV infection because of biologic susceptibility, economic dependence on their male partners, and difficulties negotiating condom use in their sexual relationships. A method of HIV prevention that a woman could control, such as a vaginal microbicide, could help overcome some of these disparities and save many lives.

The issue includes the following articles:

 *   Clinical Research Update<http://www.fhi.org/en/RH/Pubs/fhr/v2_2/clinical_research.htm>
 *   Evaluating Tenofovir Gel in South Africa<http://www.fhi.org/en/RH/Pubs/fhr/v2_2/tenofovir_gel_in_SA.htm>
 *   Participating in Microbicide Trials<http://www.fhi.org/en/RH/Pubs/fhr/v2_2/participating_in_microbicide_trials.htm>
 *   Preparing for Microbicides<http://www.fhi.org/en/RH/Pubs/fhr/v2_2/preparing_for_microbicides.htm>
 *   Resources: Research and Advocacy Partnerships<http://www.fhi.org/en/RH/Pubs/fhr/v2_2/resources.htm>

To order a hard copy of the issue, please send a request to [log in to unmask]<mailto:[log in to unmask]>.

To manage subscriptions/passwords, or view archives, go to http://listserv.yorku.ca/archives/click4hp.html . [log in to unmask] is run in collaboration with Health Nexus: http://www.healthnexus.ca/index_eng.php

ATOM RSS1 RSS2